Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Bruker Corporation
Type
Public
Traded as NASDAQ: BRKR
Founded 1960 in Germany
Founder Professor Günther Laukien
Headquarters Billerica, Massachusetts, USA
Key people
Dr. Frank Laukien, President & CEO; William Knight, COO
Revenue IncreaseUS$ 1.62 billion (2015)[1]
Number of employees
6000
Website www.bruker.com

Bruker Corporation is a manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts and is the publicly traded parent company of Bruker Scientific Instruments (Bruker AXS, Bruker BioSpin, Bruker Daltonics and Bruker Optics) and Bruker Energy & Supercon Technologies (BEST) divisions.

In April 2010, Bruker created a Chemical Analysis Division (headquartered in Fremont, CA) under the Bruker Daltonics subsidiary. This division contains three former Varian product lines: ICPMS systems, laboratory gas chromatography (GC), and GC-triple quadrupole mass spectrometer (originally designed by Bear Instruments and acquired by Varian in 2001).

In 2012 it sponsored the Fritz Feigl Prize, and since 1999 the company has also sponsored the Günther Laukien Prize.

The company was founded on September 7, 1960, in Karlsruhe, Germany as Bruker-Physik AG by five people, one of them being Günther Laukien, who was a professor at the University of Karlsruhe at the time. The name Bruker originates from co-founder Emil Bruker, as Günther Laukien himself was formally not allowed to commercialize his research whilst being a professor. Bruker produced Nuclear Magnetic Resonance Spectroscopy (NMR) and EMR spectroscopy equipment then. In the early 1960s, the company had around 60 employees and was growing rapidly. One of the early success products was the HFX 90 NMR spectroscopy system, with three independent channels and which was also the first NRM system using only semiconductor transistors. In 1969, Bruker launched the first commercial Fourier transform NMR spectroscopy system (FT-NMR) and in the 1970s the company was the first to commercialize a superconducting FT-NMR. Later, the company would expand their product range with MRI, FTIR and FT-Raman spectrometers and with mass spectrometers.

In 1968, Bruker shipped NMR systems to Yale University in Connecticut. After that, demand from the United States grew, so Bruker opened an office in Elmsford, New York which marked the start of their US activities. In 2008 after a corporate reorganization lasting 8 years, all divisions were merged in a unified Bruker Corporation.

Günther Laukien died in 1997, his son Frank D. Laukien, is currently the CEO of Bruker. His son Jörg C. Laukien, also works for the company. His son Dirk D. Laukien is a former company executive.

In 1964, the company bought the NMR division of the Swiss Trüb-Täuber.

Bruker made several offers to take over its supplier Oxford Instruments during the 1970s, but after almost a decade of negotiations, an acquisition was eventually rejected by Oxford Instruments.

In 1997, the analytical X-ray division of Siemens was acquired by Bruker.

In 2010 Bruker bought 3 product lines from Agilent, which Agilent had acquired from Varian. These included mass spectrometry and gas chromatography instruments. They have since divested these products to Scion Instruments with the exception of the triple quadrupole

In 2012 Bruker bought parts of Carestream Health, including their in-vivo imaging portfolio and related aspects.

Bruker develops and delivers a wide variety of professional and scientific analysis devices including:

Bruker products are used globally in a variety of situations. The National High Magnetic Field Laboratory at Florida State University selected Bruker to build the world's first 21.0 tesla FT-ICR MS.

The Total Carbon Column Observing Network uses high resolution FT spectrometers made by Bruker to measure various greenhouse gases across the globe.

In May, 2004, Frost & Sullivan selected the Company's Bruker Daltonics subsidiary for their 2004 Product Line Innovation Award for the Life Sciences. Bruker Daltonics received this award for its innovative development of sophisticated mass spectrometers.

Investment goal date:
Dividends reinvested
Bruker Corporation BRKR report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q1 2018
2018-05-04
--
--
Q4 2017
2018-02-14
--
--
Q4 2017
2018-02-12
--
--
Q3 2017
2017-11-02
--
--
Q3 2017
2017-11-02
0.2900
0.2300
Q2 2017
2017-08-03
0.2300
0.1500
Q1 2017
2017-05-03
0.1900
0.1300
Q4 2016
2017-02-13
0.4600
0.4300
Q3 2016
2016-11-02
0.3200
0.2900
Q2 2016
2016-08-02
0.2000
0.0900
Q1 2016
2016-05-04
0.2100
0.1400
Q4 2015
2016-02-10
0.3800
0.3600
Q3 2015
2015-11-04
0.1900
0.0700
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
ACADIAN ASSET MANAGEMENT LLC
5424653
ALLIANCEBERNSTEIN L.P.
2545001
Allianz Asset Management AG
1829100
BlackRock Inc.
4607722
BlackRock Institutional Trust Company, N.A.
2795567
Boston Partners
2676228
D. E. Shaw & Co., Inc.
1648909
FMR LLC
7146000
GOLDMAN SACHS GROUP INC
1588062
OPPENHEIMER FUNDS INC
3205720
PRICE T ROWE ASSOCIATES INC /MD/
28828478
Select Equity Group, L.P.
2083641
STATE STREET CORP
1400585
Vanguard Group, Inc
9832452
VICTORY CAPITAL MANAGEMENT INC
1806887
Major Shareholders
Name Relationship
Total Shares
Holding stocks
LAUKIEN JOERG C
9.0500% (15212295)
BRKR /
LAUKIEN DIRK D
9.4400% (15862972)
BRKR /
LAUKIEN FRANK H
22.4900% (37791386)
BRKR /
KNISS RICHARD
0.0200% (40753)
BRKR /
WAGNER CHARLES F JR
0.0600% (99925)
BRKR /
WANGLER BERNHARD
0.0100% (20250)
BRKR /
PACKER RICHARD A
0.0200% (33684)
BRKR / TFX /
LINTON WILLIAM A
0.0300% (51327)
BRKR /
MATTACCHIONE ANTHONY L
0.0200% (34726)
BRKR /
KELLER TONY WERNER
0.0100% (13340)
BRKR /
Munch Mark
0.0300% (58113)
BRKR /
Srega Juergen
0.0300% (56713)
BRKR /
Bachmann Thomas Werner
0.0200% (27700)
BRKR /
% ()